Company intelligence / Profile preview

Entegris

Billerica, Massachusetts, United Statesentegris.com ↗

Ownership: Public · ENTG
Employees: ~8200
Development stage: Other

Overview

Entegris does not conduct clinical trials or have a therapeutic pipeline. Its commercialized portfolio includes advanced materials, single-use assemblies/bags, specialty chemicals/reagents, sterile filtration devices/capsules, fluid management systems and analytical tools that enable the development/manufacture of pharmaceuticals—including monoclonal antibodies/vaccines/cell & gene therapies—by ensuring purity and process integrity at every stage from R&D through full-scale production. Their solutions were instrumental in supporting COVID‑19 vaccine production by major pharma companies.

Modalities: Monoclonal antibody manufacturingCell therapy manufacturingGene therapy manufacturingVaccine production
Industry: Chemicals & Materials

Partnerships

Partners broadly with leading global pharmaceutical/biopharmaceutical manufacturers as an enabling supplier.

Financials

Market cap: $21B
Total revenue: $883.2M
Enterprise value: $24.2B

Beyond the preview

Go deeper on Entegris.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Entegris.

Explore the full profile